Increased chitotriosidase activity in plasma of patients with type 2 diabetes

about

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

Item

http://www.wikidata.org/entity/Q37243033

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

@en

Increased chitotriosidase activity in plasma of patients with type 2 diabetes.

@nl

type

Item

label

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

@en

Increased chitotriosidase activity in plasma of patients with type 2 diabetes.

@nl

prefLabel

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

@en

Increased chitotriosidase activity in plasma of patients with type 2 diabetes.

@nl

P1476

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

@en

P2093

Anna Rorbach-Dolata

http://www.w3.org/2001/XMLSchema#string

Maria Knapik-Kordecka

http://www.w3.org/2001/XMLSchema#string

P2860

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

Self-reported effects of attending the Health Foundation's Co-Creating Health self-management programme for patients with type 2 diabetes mellitus in London, England

Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity.

Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance.

Metformin and its clinical use: new insights for an old drug in clinical practice.

Role of chitotriosidase (chitinase 1) under normal and disease conditions.

Impact of diabetes on cardiovascular disease: an update.

Serum chitotriosidase, a putative marker of chronically activated macrophages, increases with normal aging.

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus.

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study.

P304

977-984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2016.60093

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ewa Żurawska-Płaksej

Agnieszka Piwowar

P577

2016-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27695487

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5016580

http://www.w3.org/2001/XMLSchema#string